BC Innovations | Feb 19, 2015
Distillery Therapeutics

Therapeutics: Kallikrein-related peptidase 5 (KLK5); KLK7; KLK14; suppression of tumorigenicity 14 (ST14; matriptase)

Dermatology INDICATION: Dermatology In vitro and mouse studies have identified coumarin-3-carboxylate-based protease inhibitors that could help treat skin diseases such as Netherton syndrome, which is characterized by high levels of Kallikrein-related protease activity in the...
Items per page:
1 - 1 of 1